Haiti’s official COVID-19 case counts remained strikingly low compared to neighboring Caribbean countries through the spring and early summer of 2020, prompting debate about whether the numbers reflected genuine epidemiological reality or severe undercounting due to extremely limited testing capacity. Public health experts leaned heavily toward the latter explanation.
Haiti’s laboratory testing infrastructure was among the most limited in the hemisphere, with a small number of facilities capable of processing PCR tests and a logistics system for collecting and transporting samples that was entirely inadequate for pandemic-scale testing. In the absence of widespread testing, cases were counted only when people presented to healthcare facilities — and in a country where healthcare access was severely limited and trust in institutions was low, most sick people stayed home.
Excess mortality analysis — comparing death rates during the pandemic period to historical averages — suggested that the true death toll from COVID and its knock-on effects on healthcare access was significantly higher than official COVID deaths indicated. The pandemic had reduced access to care for all conditions, not just COVID, and people who died of treatable illnesses because they could not reach functioning healthcare facilities were casualties of the pandemic even if they never tested positive for the virus.
The limited testing also had implications for pandemic response. Without data on where transmission was occurring, public health authorities could not target interventions effectively. The epidemiological blind spot created by inadequate testing made evidence-based pandemic management essentially impossible.